Scott Jordan - Net Worth and Insider Trading
Scott Jordan Net Worth
The estimated net worth of Scott Jordan is at least $597 dollars as of 2024-05-21. Scott Jordan is the Chief Business Officer of Salarius Pharmaceuticals Inc and owns about 1,264 shares of Salarius Pharmaceuticals Inc (SLRX) stock worth over $597. Details can be seen in Scott Jordan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott Jordan has not made any transactions after 2020-02-18 and currently still holds the listed stock(s).
Transaction Summary of Scott Jordan
Scott Jordan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott Jordan owns 1 companies in total, including Salarius Pharmaceuticals Inc (SLRX) .
Click here to see the complete history of Scott Jordan’s form 4 insider trades.
Insider Ownership Summary of Scott Jordan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SLRX | Salarius Pharmaceuticals Inc | 2020-02-18 | Chief Financial Officer |
Scott Jordan Latest Holdings Summary
Scott Jordan currently owns a total of 1 stock. Scott Jordan owns 1,264 shares of Salarius Pharmaceuticals Inc (SLRX) as of February 18, 2020, with a value of $597.
Latest Holdings of Scott Jordan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SLRX | Salarius Pharmaceuticals Inc | 2020-02-18 | 1,264 | 0.47 | 597 |
Holding Weightings of Scott Jordan
Scott Jordan Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott Jordan has made a total of 1 transactions in Salarius Pharmaceuticals Inc (SLRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Salarius Pharmaceuticals Inc is the acquisition of 452 shares on February 18, 2020, which cost Scott Jordan around $10,170.
Insider Trading History of Scott Jordan
- 1
Scott Jordan Trading Performance
GuruFocus tracks the stock performance after each of Scott Jordan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott Jordan is 2.66%. GuruFocus also compares Scott Jordan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott Jordan within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Scott Jordan's insider trading performs compared to the benchmark.
Performance of Scott Jordan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -26.78 | | | | | |
| Relative Return to S&P 500(%) | 2.07 | | | | | |
Scott Jordan Ownership Network
Scott Jordan Owned Company Details
What does Salarius Pharmaceuticals Inc do?
Who are the key executives at Salarius Pharmaceuticals Inc?
Scott Jordan is the Chief Financial Officer of Salarius Pharmaceuticals Inc. Other key executives at Salarius Pharmaceuticals Inc include Exec VP Finance & Interim CFO Mark J Rosenblum , director & Chief Executive Officer David J. Arthur , and Controller Pao-yu Chuang .
Salarius Pharmaceuticals Inc (SLRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Salarius Pharmaceuticals Inc (SLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Salarius Pharmaceuticals Inc (SLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Salarius Pharmaceuticals Inc (SLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Salarius Pharmaceuticals Inc Insider Transactions
Scott Jordan Mailing Address
Above is the net worth, insider trading, and ownership report for Scott Jordan. You might contact Scott Jordan via mailing address: 2450 Holcome Blvd., Suite J-608, Houston Tx 77021.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
